<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.6.5" -->
<rss version="0.92">
<channel>
	<title>htgenomics.com</title>
	<link>http://www.htgenomics.com</link>
	<description></description>
	<lastBuildDate>Tue, 09 Mar 2010 22:46:38 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>HTG’s qNPA™ Technology selected for BARDA Grant</title>
		<description>ASU leads $40 million effort to rapidly assess radiation exposures
Dec. 21, 2009

TEMPE, Ariz.--Arizona State University will lead a $40.8 million, multi-institutional research program to develop systems that would rapidly measure an individual’s level of exposure to radiation in the event of a radiological or nuclear incident. In the event of ...</description>
		<link>http://www.htgenomics.com/htg%e2%80%99s-qnpa%e2%84%a2-technology-selected-for-barda-grant-544.htm</link>
			</item>
	<item>
		<title>Roche and High Throughput Genomics Partner for Advanced Gene Expression Analysis Solution</title>
		<description>Roche NimbleGen (SIX: RO, ROG; OTCQX: RHHBY) and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA), have entered into a supply agreement. Under the agreement, Roche NimbleGen will provide HTG with high density, multiplex DNA microarray slides for advanced gene expression analysis. 

HTG will apply ...</description>
		<link>http://www.htgenomics.com/roche-and-high-throughput-genomics-partner-for-advanced-gene-expression-analysis-solution-535.htm</link>
			</item>
	<item>
		<title>HTG ANNOUNCES AVAILABILITY OF 96 MAX GENE EXPRESSION ASSAY</title>
		<description>HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) today announced the launch of the quantitative Nuclease protection assay (qNPA™) 96 Max gene expression assay at the American Association of Cancer Research (AACR) annual meeting. This new testing configuration enables the measurement of 46 genes in a 96 well ...</description>
		<link>http://www.htgenomics.com/htg-announces-availability-of-96-max-gene-expression-assay-at-298.htm</link>
			</item>
	<item>
		<title>HTG and CRL Form Partnership</title>
		<description>HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) and service partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL Global Services), provider of testing
services for toxicology, molecular diagnostics, clinical trials, bioanalytics, and insurance today
announced they signed a multi-year agreement. Under the terms of the agreement, ...</description>
		<link>http://www.htgenomics.com/htg-and-crl-form-partnership-250.htm</link>
			</item>
	<item>
		<title>HTG Collaborates with HC-LITT</title>
		<description>HTG SIGNS COLLABORATION AGREEMENT WITH HARVARD CATALYST LABORATORY FOR INNOVATIVE TRANSLATIONAL TECHNOLOGIES AT HARVARD MEDICAL SCHOOL

Tucson, Ariz.—December 1, 2008—HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) system and service partner for the life sciences industry, today announced a collaboration agreement with researchers at Harvard Catalyst Laboratory for Innovative ...</description>
		<link>http://www.htgenomics.com/203-203.htm</link>
			</item>
	<item>
		<title>Fred Pollock Joins HTG</title>
		<description>HTG NAMES FREDRICK POLLOCK VP OF CORPORATE DEVELOPMENT

Tucson, Ariz.—November 24, 2008— HTG, Inc., provider of the quantitative Nuclease Protection Assay (qNPA™) system and service partner for the life sciences industry, today announced it has appointed Fredrick L. Pollock to Vice President of Corporate Development. Pollock will be responsible for leading ...</description>
		<link>http://www.htgenomics.com/fred-pollock-joins-htg-204.htm</link>
			</item>
	<item>
		<title>qNPA™ Technology Animation</title>
		<description>Click here to view a Technical Animation of the qNPA™ ArrayPlate. </description>
		<link>http://www.htgenomics.com/qnpaanimation-146.htm</link>
			</item>
	<item>
		<title>Technology Information</title>
		<description>Academic Research
Applications
FFPE Tissue in the qNPA ArrayPlate System
miRNA in the qNPA Arrayplate

Brochures
High Throughput Gene Expression Analysis
Measuring miRNA with qNPA Technology 

Instruments
Capella Imager
Omix II Imager

Products
qFix qNPA ArrayPlate
Drug Discovery
Applications
FFPE Tissue in the qNPA ArrayPlate System
miRNA in the qNPA Arrayplate

Brochures
Multiplexed Biomarker-Driven Drug Discovery
Measuring miRNA with qNPA Technology 

Instruments
Omix HD Imager

Products
qFix qNPA ArrayPlate </description>
		<link>http://www.htgenomics.com/technology-information-194.htm</link>
			</item>
	<item>
		<title>Upcoming shows</title>
		<description>
March 22 - 24 - USCAP  
The Marriot Wardman Park
Washington, D.C.
Booth # 1513

April 17 -21 - AACR 
Washington, D.C.
Booth # 140

April 28 - 30 - Tri-State Spring Symposium 
West Des Moines. IA


 </description>
		<link>http://www.htgenomics.com/upcoming-shows-108.htm</link>
			</item>
	<item>
		<title>qNPA™ Technology in Fixed Tissues (FFPE)</title>
		<description>How does qNPA analyze gene expression in FFPE material without RNA extraction?

In most fixed tissue specimens, the majority of RNA is cross-linked to cellular material, much of which is insoluble and is therefore resistant to RNA extraction. qNPA oligonucleotides can hybridize to these tissue-bound RNAs and the nuclease protection assay can ...</description>
		<link>http://www.htgenomics.com/ffpe_faq-172.htm</link>
			</item>
</channel>
</rss>
